Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CEPH -- Ignore unavailable to you. Want to Upgrade?

To: m33806 who wrote (790)	6/8/1998 11:17:00 PM
From: virgil vancleave	Read Replies (2) \| Respond to of 998

looks like the chart has given us a nice double bottom here which is somewhat bullish. fact is that myo and provigal could both be approved soon which will put ceph well on its way to nice profits. they also have a web page which is very informative and gives a nice overview of some of their other products in the research pipeline. i wonder when they will get back to the fda and get approval. i hope soon. all the same, ceph still has plenty of cash to continue and it is just a matter of time before another drug makes the stock. it is a safe hold here in my opinion